| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/CCLM.2007.083 |
| P698 | PubMed publication ID | 17378727 |
| P50 | author | Karine Clément | Q62104165 |
| P2093 | author name string | Soraya Taleb | |
| P2860 | cites work | Obesity, Metabolic Syndrome, and Cardiovascular Disease | Q22241664 |
| Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss | Q22241931 | ||
| Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading | Q24328923 | ||
| The cystatins: Protein inhibitors of cysteine proteinases | Q28283958 | ||
| Emerging roles for cysteine proteases in human biology | Q28306260 | ||
| Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3 | Q28567588 | ||
| Cathepsin S required for normal MHC class II peptide loading and germinal center development | Q28611850 | ||
| Atherosclerosis is an inflammatory disease | Q33762068 | ||
| Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
| Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications | Q34034147 | ||
| Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization | Q34084203 | ||
| Human epicardial adipose tissue is a source of inflammatory mediators | Q34272633 | ||
| Adipokines: inflammation and the pleiotropic role of white adipose tissue | Q34356530 | ||
| Obesity, haemostasis and the fibrinolytic system | Q34743382 | ||
| Minireview: Adiposity, Inflammation, and Atherogenesis | Q35127246 | ||
| Adiponectin and atherosclerotic disease | Q35776566 | ||
| Inflammation as a cardiovascular risk factor | Q35789860 | ||
| Lysosomal cysteine proteases in atherosclerosis | Q35792643 | ||
| Inflammation, insulin resistance, and obesity. | Q35918777 | ||
| Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease | Q36139688 | ||
| Mechanisms of endothelial dysfunction in obesity | Q36176668 | ||
| Cathepsin S activity regulates antigen presentation and immunity | Q37382422 | ||
| Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells | Q37384330 | ||
| Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss | Q38323163 | ||
| Macrophage-secreted factors induce adipocyte inflammation and insulin resistance | Q40326610 | ||
| Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors | Q40926709 | ||
| Adipogenesis and obesity: rounding out the big picture | Q41193513 | ||
| Expression of rat cathepsin S in phagocytic cells | Q41226814 | ||
| Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice | Q41855757 | ||
| Primary structure of bovine cathepsin S. Comparison to cathepsins L, H, B and papain | Q42622492 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction | Q44924295 | ||
| Circulating mononuclear cells in the obese are in a proinflammatory state | Q45057039 | ||
| Increased serum cathepsin S in patients with atherosclerosis and diabetes | Q46685170 | ||
| Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women | Q46880197 | ||
| Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation | Q50335753 | ||
| From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. | Q51683141 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 328-332 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
| P1476 | title | Emerging role of cathepsin S in obesity and its associated diseases | |
| P478 | volume | 45 |
| Q36964973 | Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity |
| Q29042565 | Cathepsin K inhibitors for osteoporosis and potential off-target effects |
| Q53109387 | Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. |
| Q37575442 | Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. |
| Q37082769 | Cysteine cathepsin S as an immunomodulatory target: present and future trends. |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q30669834 | Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity |
| Q33870787 | Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review |
| Q33653550 | Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse |
| Q30404426 | Thiazolidinediones regulate adipose lineage dynamics |
| Q28727779 | Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial |
| Q43415222 | Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity |
Search more.